Human Papillomavirus Current Events | Human Papillomavirus News | 2
|
|
|
Sort By:
Page Views | Date |
How cow warts, clergy sex surveys moved along cancer vaccine
The creation of a successful vaccine against cervical cancer, approved today by the U.S. Food and Drug Administration, is the culmination of research that occurred thanks not only to scientists and physicians, but also to generous farmers and veterinarians, priests and nuns willing to tell all — and some very patient cows. view more (2006-06-12)
UAB researchers report breakthrough in HPV research
UAB (University of Alabama at Birmingham) researchers have developed a new, inexpensive and efficient method for producing and studying a type of human papillomavirus (HPV) that causes cervical cancer. The process could speed understanding of how the virus functions and causes diseases, and lead to new prevention or treatment options. view more (2009-02-24)
'WAIT AND SEE' POLICY' SUGGESTED FOR WOMEN WITH ABNORMAL CERVICAL SMEARS IN PRESENCE of HIGH-RISK HUMAN PAPILLOMAVIRUS (p 1782)
Women with abnormal cervical smears (mild to moderate dyskaryosis) and who are positive for the high-risk form of human papillomavirus (HR-HPV) should not be treated for at least 6 months after cytological screening to see if the virus disappears, suggest authors of a research letter in this week's issue of THE LANCET. If viral clearance occurs,... view more... (2001-11-21)
HPV infection common among females in US
Data from a national study suggests that about one in four U.S. females between the ages of 14 and 59 years may have the sexually transmitted infection human papillomarivus (HPV), according to a study in the February 28 issue of JAMA. view more (2007-02-28)
Scientists identify common HPV genotypes in northern India, encourage vaccination
Although a wide spectrum of human papillomavirus is seen across the population of India, HPV-16 and HPV-18 are the most common types and a vaccination targeting these types could eliminate 75 percent of the cervical cancers in the region. view more (2009-10-12)
HPV testing finds precancerous lesions at a higher rate than conventional pap smears
Human papillomavirus (HPV) testing was more sensitive than traditional Pap smears at detecting precancerous lesions of the cervix. view more (2006-06-07)
Vaccinating boys against human papillomavirus not cost-effective
Persistent infection with high-risk types of human papillomavirus (HPV), a sexually transmitted virus, is known to be a cause of cervical cancer. view more (2009-10-09)
Rare head and neck cancer linked to HPV, study finds
An increase in cases of a rare type of head and neck cancer appears to be linked to HPV, or human papillomavirus, according to a new study from researchers at the University of Michigan Comprehensive Cancer Center. view more (2009-10-08)
Combination vaccine protects monkeys from ebola and Marburg viruses
An experimental, combination vaccine against Ebola and Marburg viruses using virus-like particles (VLPs) provides complete protection against infection in monkeys. view more (2008-02-27)
A New Startup Fund Called EMERTEC
CEA (the French Atomic Energy Commission) and the Caisse des Dépôts et Consignations (CDC) promoted the setup of EMERTEC, a new startup fund for investing in new high technology companies on emerging, booming markets. The shares issue has been open since January 2000 and has already raised 120 million francs out of the 160-million... view more... (2000-06-20)
HPV-vaccine may prevent preterm births
Chronic human papilloma virus (HPV)-infections can lead to cellular changes in the cervix that can be a pre-stage to cervical cancer. Surgical treatment of these pre-stages gives an increased risk of preterm birth in subsequent pregnancies. view more (2009-03-17)
CHANGING TRENDS OF UK CERVICAL CANCER SUGGESTS POSITIVE EFFECT OF SCREENING ON SPECIFIC SUBTYPE (p 1490)
Recent cervical cancer data compared with data from previous decades suggest that cervical screening is having a positive effect in reducing incidence of a subtype of the disease that was not previously thought to be influenced by screening, conclude authors of a study in this week's issue of THE LANCET. A recent analysis showed little or no... view more... (2001-05-09)
Cervical cancer - a single vaccine could benefit most women
The risk of developing cervical cancer by women infected with the Human Papillomavirus (HPV) is essentially the same no matter which type of virus is involved, provided it belongs to the group of 15 or so that are currently identified as high risk, a scientist said today. view more (2003-09-20)
Cervical cancer screening: Too many are left unprotected
The decline in cervical cancer is a success story of cancer research. Although there are reasons to be optimistic about even further decreases in cervical cancer incidence, there still remain some women who are not screened. view more (2007-09-20)
UNC study firms up promise of potential new cervical cancer screening tool
New research into the causes of cervical cancer appears to lend weight to the promise of a potential early detection method that could help prevent the disease. view more (2008-05-22)
Cervical cancer prevention should focus on vaccinating adolescent girls
The cost-effectiveness of vaccination in the United States against human papillomavirus (HPV), a sexually-transmitted virus that causes cervical cancer, will be optimized by achieving universal vaccine coverage in young adolescent girls, by targeting initial "catch-up" efforts to vaccinate women younger than 21 years of age, and by... view more... (2008-08-21)
New study shows potential to treat or prevent viral cancers
A new study, presented at the SNM 55th Annual Meeting, shows that radioimmunotherapy (RIT) targeting viral antigens offers a novel option to treat-or even prevent-many viral cancers by targeting cancer cells expressing viral antigens or infected cells before they convert into malignancy. view more (2008-06-17)
HPV vaccine does not appear to be effective for treating pre-existing HPV infection
For women with human papillomavirus (HPV) infection, use of the HPV-16/18 vaccine will not accelerate reduction of the virus and should not be used to treat the infection, according to a study in the August 15 issue of JAMA. view more (2007-08-15)
Updated data on novel HPV vaccine confirms efficacy in large population
Updated data from a study on a promising new vaccine against a pre-cancerous cervical virus shows superior efficacy in preventing cervical pre-cancers and non-invasive cervical cancer. view more (2005-11-01)
HIV-1-Positive Women At Increased Risk Of Genital Cancer
A study in this week's issue of THE LANCET suggests that women who are HIV-1 positive are at an increased risk of invasive genital cancer. Authors of the study recommend that gynaecological examination of these women should include examination of the vulva and perianal region to identify genital warts, which can lead to the development of invasive... view more... (2002-01-11)
|
|
|
|
Sort By:
Page Views | Date |
|
